Nasdaq
EVO
Evotec SE
- Health Care
- Germany
- Listed 2021
- 1 day
- −1.5%
- 1 month
- −31.6%
- 1 year
- −48.0%
$1.95 · Mkt cap $694M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Evotec SE
$1.95 · Mkt cap $694M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Evotec SE trades under the ticker EVO on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $694M. The last closing price was $1.95, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −48.0%, and −31.6% over the past month. Returns are price returns and exclude dividends.
This page exists because EVO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.